CWP
LMAT icon

Concord Wealth Partners’s LeMaitre Vascular LMAT Stock Holding History

Concord Wealth Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-61
Closed -$4.95K – 536
2025
Q4 		$4.95K Sell
61
-8
-12% -$689 ﹤0.01% 623
2025
Q3 		$6.04K Hold
69
– – ﹤0.01% 590
2025
Q2 		$5.73K Buy
69
+10
+17% +$836 ﹤0.01% 612
2025
Q1 		$4.95K Hold
59
– – ﹤0.01% 586
2024
Q4 		$5.44K Hold
59
– – ﹤0.01% 595
2024
Q3 		$5.48K Buy
59
+8
+16% +$693 ﹤0.01% 623
2024
Q2 		$4.2K Hold
51
– – ﹤0.01% 592
2024
Q1 		$3.38K Buy
+51
New +$3.15K ﹤0.01% 698

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Concord Wealth Partners's LMAT Position: Q1 2026 in Review

Concord Wealth Partners sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 61 shares — an estimated $4.95K sold.

Concord Wealth Partners first reported a position in LMAT in Q1 2024 and held it in 8 quarters. The position peaked at $6.04K in Q3 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Concord Wealth Partners reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • Concord Wealth Partners sold 61 LeMaitre Vascular shares in Q1 2026, an estimated $4.95K.
  • Concord Wealth Partners first reported a position in LeMaitre Vascular in Q1 2024 and held it in 8 quarters.
  • Concord Wealth Partners's LeMaitre Vascular position peaked at $6.04K in Q3 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Concord Wealth Partners's 13F filing for Q1 2026, filed 1 May 2026.